Aquatic_Training in Obese Women

April 14, 2024 updated by: YUNG-SHENG CHEN, University of Taipei

Effect of Water-based Aerobic Training on Anthropometric, Biochemical, Cardiovascular, and Explosive Strength Parameters in Young Overweight and Obese Women

This study aims to assess the effects of 10-week water-based aerobic training (thrice a week) on anthropometrics, biochemicals, cardiovascular parameters, and explosive strength in young overweight and obese women. The findings indicate that water-based aerobic training could be a useful program to enhance body composition, biochemical, cardiovascular, and explosive strength parameters in young overweight and obese women compared to inactive persons

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study is based on a randomized controlled trial with a pre-to-post testing design, twenty-seven young overweight and obese women were assigned to training group (a water-based aerobic training) or control group (maintaining their usual activities during the studying period. For each training session, water activities were implemented for 50 min which included warm-up (10 min), main activities (30 min), and cool-down (10 min). The swimming pool where the intervention took part was 1.50 m deep of water. The pre- and post-intervention participants were assessed for their anthropometrics, biochemicals (fasting glycemia, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol and triglyceride (TG)), resting blood pressure, and resting heart rate, and explosive strength of upper (countermovement jump and squat jump) and lower limbs (a seated medicine ball throw test).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
31

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taipei, Taiwan, 11153
        • Department of Exercise and Health Sciences, University of Taipei

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 20 and 35 years
  • Sedentary lifestyle within six month
  • Not using drugs or other therapy for obesity.

Exclusion Criteria:

  • BMI below 25.0 and over 34.9 kg.m-2
  • having any infectious or skin diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Training group
Performing a 10-week water-based aerobic training (thrice/week)
Other: 10-week water-based aerobic training
The water-based aerobic program was adopted from the protocol previously used by Costa et al. (2018, 2020). This training program was carried out thrice a week over 2 non-consecutive days 48 hours apart for 10 weeks according to ACSM guidelines
No Intervention: Control group
Maintaining their usual activities during the interventional period

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
fasting glycemia in millimoles per liter
Time Frame: 3 days before the 10-week interventional period
baseline blood sample
3 days before the 10-week interventional period
total cholesterol in millimoles per liter
Time Frame: 3 days before the 10-week interventional period
baseline blood sample
3 days before the 10-week interventional period
high-density lipoprotein cholesterol in millimoles per liter
Time Frame: 3 days before the 10-week interventional period
baseline blood samplelipoprotein cholesterol, and triglyceride concentrations
3 days before the 10-week interventional period
low-density lipoprotein cholesterol in millimoles per liter
Time Frame: 3 days before the 10-week interventional period
baseline blood sample
3 days before the 10-week interventional period
triglyceride concentrations in millimoles per liter
Time Frame: 3 days before the 10-week interventional period
baseline blood sample
3 days before the 10-week interventional period
systolic blood pressure in millimeters of mercury
Time Frame: 3 days before the 10-week interventional period
baseline blood sample
3 days before the 10-week interventional period
diastolic blood pressure in millimeters of mercury
Time Frame: 3 days before the 10-week interventional period
baseline blood sample
3 days before the 10-week interventional period
heart rate in beat per minute
Time Frame: 3 days before the 10-week interventional period
baseline blood sample
3 days before the 10-week interventional period
fasting glycemia in millimoles per liter
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period
total cholesterol in millimoles per liter
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period
high-density lipoprotein cholesterol in millimoles per liter
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period
low-density lipoprotein cholesterol in millimoles per liter
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period
triglyceride concentrations in millimoles per liter
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period
systolic blood pressure in millimeters of mercury
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period
diastolic blood pressure in millimeters of mercury
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period
heart rate in beat per minute
Time Frame: one day after the 10-week interventional period
post-training blood sample
one day after the 10-week interventional period

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
countermovement jump in centimetres
Time Frame: 3 days before the 10-week interventional period
baseline lower limbs power test
3 days before the 10-week interventional period
squat jump in centimeters
Time Frame: 3 days before the 10-week interventional period
baseline lower limbs power test
3 days before the 10-week interventional period
chest 3-kg medicine ball throw in meters
Time Frame: 3 days before the 10-week interventional period
baseline upper limbs power test
3 days before the 10-week interventional period
countermovement jump in centimetres
Time Frame: one day after the 10-week interventional period
post-training lower limbs power test
one day after the 10-week interventional period
squat jump in centimeters
Time Frame: one day after the 10-week interventional period
post-training lower limbs power test
one day after the 10-week interventional period
chest 3-kg medicine ball throw in meters
Time Frame: one day after the 10-week interventional period
post-training upper limbs power test
one day after the 10-week interventional period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Taipei

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Yung-Sheng Chen, Ph.D., Department of Exercise and Health Sciences, University of Taipei

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 2, 2019

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 30, 2019

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 30, 2019

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 28, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 14, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 17, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 17, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 14, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 014_2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings